Dr. Ziyad M. HijaziMD, MPH, FSCAI, FACC
Course Director, Pediatric and Adult Interventional Cardiac Symposium (PICS)
Director, Rush Center for Congenital and Structural Heart Disease
Professor of Pediatrics and Internal Medicine
Section Chief Pediatric Cardiology
at Rush University Medical Center, Chicago, IL
Ziyad Hijazi, MD, MPH, earned his medical degree and completed an internship at Jordan University School of Medicine in Amman, Jordan, before coming to the United States to begin postgraduate training in the Department of Epidemiology and Public Health at Yale University. Upon completing his Master of Public Health degree, Dr. Hijazi remained at Yale for his residency in pediatrics and a fellowship in pediatric cardiology. He spent eight years on the faculty at Tufts University School of Medicine and another eight years at the University of Chicago before joining the faculty at Rush University Medical Center as Director of the Rush Center for Congenital and Structural Heart Disease in 2007.
Throughout his career, Dr. Hijazi has been a pioneer in the non surgical repair of congenital heart defects. In addition to being widely published in his area of expertise, he has led groundbreaking national clinical trials of novel transcatheter closure devices for the treatment of atrial septal defects (ASD) , ventricular septal defects, patent ductus arteriosys and patent foramen ovale (PFO). As a result of his research, the FDA approved the first ASD closure device for use in children in 2001.
His work has not been limited to the nonsurgical repair of cardiac defects. Dr. Hijazi was the first to describe how intracardiac echocardiography can be used to assist in guiding transcatheter closure of ASD and PFO. Currently, he is evaluating percutaneous valve implantation for patients with defective pulmonary valves; in 2005, Dr. Hijazi became the first in the United States to perform this innovative procedure.
Dr. Hijazi is also Course Director for the Pediatric Interventional Cardiac Symposium, an annual four-day conference that brings together a select international faculty who provide demonstrations, live operations and the latest breakthroughs in interventional cardiology for congenital heart disease. This symposium attracts more than 800 interventional cardiologists from more than 60 countries.
A skilled clinician and a pioneering researcher, Dr. Hijazi will be an enormous asset to Rush University Medical Center, greatly enhancing the hospitals ability to provide outstanding care for pediatric and adult patients with congenital and structural/valvular heart disease.